CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $32,414,000 | +52.2% | 549,293 | +52.2% | 0.01% | +83.3% |
| Q4 2021 | $21,296,000 | +16.6% | 360,888 | +16.6% | 0.01% | 0.0% |
| Q3 2021 | $18,258,000 | +1.2% | 309,393 | +1.2% | 0.01% | +20.0% |
| Q2 2021 | $18,049,000 | -25.3% | 305,870 | -25.3% | 0.01% | -37.5% |
| Q1 2021 | $24,170,000 | +2.8% | 409,605 | +2.8% | 0.01% | 0.0% |
| Q4 2020 | $23,503,000 | +1.1% | 398,282 | +1.1% | 0.01% | -11.1% |
| Q3 2020 | $23,242,000 | +11.7% | 393,857 | +11.7% | 0.01% | +12.5% |
| Q2 2020 | $20,815,000 | +841.0% | 352,732 | +1.4% | 0.01% | +700.0% |
| Q1 2020 | $2,212,000 | -37.5% | 347,908 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $3,539,000 | +117.1% | 339,449 | -18.2% | 0.00% | 0.0% |
| Q3 2019 | $1,630,000 | -70.4% | 414,747 | +11.9% | 0.00% | -50.0% |
| Q2 2019 | $5,512,000 | +560.9% | 370,710 | +2922.5% | 0.00% | -60.0% |
| Q4 2017 | $834,000 | -17.9% | 12,265 | -0.5% | 0.01% | -28.6% |
| Q3 2017 | $1,016,000 | +50.7% | 12,330 | +71.2% | 0.01% | +75.0% |
| Q2 2017 | $674,000 | -58.1% | 7,200 | -60.7% | 0.00% | -55.6% |
| Q2 2015 | $1,610,000 | +27.9% | 18,314 | +8.0% | 0.01% | +28.6% |
| Q1 2015 | $1,259,000 | +86.2% | 16,960 | +40.5% | 0.01% | +75.0% |
| Q4 2014 | $676,000 | – | 12,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |